{
  "meta": {
    "title": "07_Arrhythmias",
    "url": "https://brainandscalpel.vercel.app/07-arrhythmias-512422e4.html",
    "scrapedAt": "2025-11-30T06:56:57.800Z"
  },
  "questions": [
    {
      "id": 75702,
      "choices": [
        {
          "id": 217960,
          "text": "Left Bundle Branch Block"
        },
        {
          "id": 217961,
          "text": "Left Anterior Fascicular block"
        },
        {
          "id": 217962,
          "text": "Left Posterior Fascicular block"
        },
        {
          "id": 217963,
          "text": "Right Bundle Branch Block"
        }
      ],
      "text": "Brugada Syndrome is associated with:",
      "unique_key": "Q2150087",
      "question_audio": null,
      "question_video": null,
      "map_id": 34553593,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Right Bundle Branch Block Explanation of the Correct Answer: Brugada Syndrome is a genetic condition that affects the electrical activity of the heart and is most commonly associated with Right Bundle Branch Block (RBBB). This syndrome can lead to an increased risk of sudden cardiac arrest due to abnormal electrical activity in the heart. The characteristic finding on an electrocardiogram (ECG) in Brugada Syndrome is a right bundle branch block pattern with ST-segment elevation in the right precordial leads (V1-V3). This abnormal pattern is a hallmark of the condition. Explanation of the Incorrect Responses: A. Left Bundle Branch Block (LBBB): Left Bundle Branch Block (LBBB) is not a typical finding in Brugada Syndrome. LBBB is a separate conduction abnormality that affects the left bundle branch, leading to delayed conduction in the left ventricle. This does not have the same ECG characteristics or clinical significance as the right bundle branch block seen in Brugada Syndrome. B. Left Anterior Fascicular Block (LAFB): Left Anterior Fascicular Block (LAFB) is another conduction abnormality, but it is not specifically associated with Brugada Syndrome. LAFB involves delayed conduction in the left anterior fascicle of the left bundle branch, which can result in changes in the QRS axis but is not characteristic of Brugada Syndrome. C. Left Posterior Fascicular Block (LPFB): Similarly, Left Posterior Fascicular Block (LPFB) is a conduction defect affecting the left posterior fascicle of the left bundle branch and does not have a direct association with Brugada Syndrome. While it can cause changes in the ECG, it is not a typical finding in patients with Brugada Syndrome.",
      "correct_choice_id": 217963,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13299561700634582/13299561700634582.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13299561700634582/13299561700634582.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75703,
      "choices": [
        {
          "id": 217964,
          "text": "Ventricular fibrillations"
        },
        {
          "id": 217965,
          "text": "Verticular premature contractions"
        },
        {
          "id": 217966,
          "text": "Atrial flutter"
        },
        {
          "id": 217967,
          "text": "Atrial fibrillation"
        }
      ],
      "text": "A chronic alcoholic develops palpitation suddenly after alcohol binge. Which of the following arrhythmia is most commonly associated with alcohol binge in the alcoholics?",
      "unique_key": "Q1561485",
      "question_audio": null,
      "question_video": null,
      "map_id": 34920026,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Atrial Fibrillation Explanation of the Correct Answer: In individuals with chronic alcoholism, Atrial Fibrillation (AF) is the most commonly associated arrhythmia, especially after an alcohol binge. This phenomenon is sometimes referred to as \"holiday heart syndrome\" because it often occurs after heavy drinking during weekends or holidays. Alcohol can induce atrial fibrillation by increasing the sympathetic tone, altering the electrophysiological properties of the atria, and promoting atrial dilation. These changes make the atria more susceptible to arrhythmias. Patients with alcohol-related AF typically present with sudden-onset palpitations, and the condition may resolve with abstinence from alcohol or with medical intervention. Explanation of the Incorrect Responses: A. Ventricular Fibrillation (VF): Ventricular fibrillation (VF) is a life-threatening arrhythmia and is typically associated with structural heart disease, ischemic heart disease, or electrical disturbances like those from electrolyte imbalances. While alcohol abuse can increase the risk of VF, it is not the most common arrhythmia associated with alcohol binge episodes. AF is more common than VF in this context. B. Ventricular Premature Contractions (VPCs): Ventricular premature contractions (VPCs), also known as premature ventricular complexes (PVCs), are early heartbeats originating from the ventricles. While alcohol can trigger VPCs, especially in individuals with electrolyte disturbances, VPCs are less commonly related to alcohol binge episodes compared to atrial arrhythmias like atrial fibrillation. C. Atrial Flutter: Atrial flutter is another supraventricular arrhythmia that can occur in individuals with structural heart disease or those with atrial dilation. However, it is less commonly associated with alcohol binge than atrial fibrillation. Atrial fibrillation is typically more prevalent in alcoholics and is more strongly linked with acute alcohol consumption.",
      "correct_choice_id": 217967,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28312311700634598/28312311700634598.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28312311700634598/28312311700634598.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75704,
      "choices": [
        {
          "id": 217968,
          "text": "Warfarin"
        },
        {
          "id": 217969,
          "text": "Dabigatran"
        },
        {
          "id": 217970,
          "text": "Rivoraxaban"
        },
        {
          "id": 217971,
          "text": "Clopidogrel"
        }
      ],
      "text": "Which of the following agents should not be used for oral anticoagulation in high risk patients with Atrial Fibrillation",
      "unique_key": "Q5089514",
      "question_audio": null,
      "question_video": null,
      "map_id": 34800961,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Clopidogrel Explanation of the Correct Answer: Clopidogrel is not suitable for oral anticoagulation in patients with atrial fibrillation (AF) who are at high risk for stroke. Clopidogrel is an antiplatelet agent, not an anticoagulant, and works by inhibiting platelet aggregation, which reduces the risk of thrombosis in conditions like coronary artery disease or after stent placement. However, it does not adequately prevent thromboembolic events like atrial fibrillation-associated strokes. Therefore, it is not recommended for stroke prevention in high-risk patients with AF. Instead, oral anticoagulants are preferred to reduce the risk of thrombus formation in the atria, which can lead to embolic stroke. Explanation of the Incorrect Responses: A. Warfarin: Warfarin is a vitamin K antagonist and has been a standard therapy for anticoagulation in atrial fibrillation patients for decades. It works by inhibiting clotting factors dependent on vitamin K, thereby reducing the risk of stroke and thromboembolism. Warfarin remains an appropriate option for patients with AF, although it requires regular monitoring of the INR (International Normalized Ratio) and dose adjustments. Despite its monitoring requirements, it is effective in preventing strokes in high-risk AF patients. B. Dabigatran: Dabigatran is a direct thrombin inhibitor and is one of the non-vitamin K oral anticoagulants (NOACs) used for stroke prevention in atrial fibrillation. It does not require routine monitoring like warfarin, making it a convenient option for patients. Dabigatran is considered effective and safe for use in high-risk AF patients and is approved as a first-line treatment for anticoagulation in atrial fibrillation. C. Rivaroxaban: Rivaroxaban is a direct factor Xa inhibitor and is another non-vitamin K oral anticoagulant (NOAC) used in atrial fibrillation to reduce the risk of stroke and systemic embolism. Like dabigatran, rivaroxaban does not require routine monitoring, making it an appealing alternative to warfarin. It is also indicated for high-risk patients with AF to prevent thromboembolic events.",
      "correct_choice_id": 217971,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21839331700634609/21839331700634609.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21839331700634609/21839331700634609.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75705,
      "choices": [
        {
          "id": 217972,
          "text": "Risk of thromboembolism"
        },
        {
          "id": 217973,
          "text": "Digoxin for treatment"
        },
        {
          "id": 217974,
          "text": "Anticoagulation not required"
        },
        {
          "id": 217975,
          "text": "Aspirin in low risk patients"
        }
      ],
      "text": "All of the following are true about Atrial Fibrillation, Except:",
      "unique_key": "Q2842602",
      "question_audio": null,
      "question_video": null,
      "map_id": 34221201,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Anticoagulation not required Explanation of the Correct Answer: In atrial fibrillation (AF), anticoagulation is generally required in patients who are at increased risk of thromboembolism (such as stroke). Atrial fibrillation causes ineffective atrial contraction and stasis of blood, which increases the risk of clot formation in the atria, particularly in the left atrial appendage. These clots can then embolize to the brain, causing a stroke. Patients with AF should be evaluated for stroke risk using scoring systems like the CHA2DS2-VASc score, and anticoagulation is recommended for those at moderate to high risk. Thus, anticoagulation is required in most patients with AF, especially those with additional risk factors. Explanation of the Incorrect Responses: A. Risk of thromboembolism: This statement is true. Atrial fibrillation increases the risk of thromboembolism, specifically ischemic stroke. Due to poor atrial contraction, blood tends to pool, leading to the formation of thrombi (blood clots) that can embolize and travel to the brain, lungs, or other organs. This is one of the main complications of AF, necessitating anticoagulation therapy in many patients to reduce the risk of stroke. B. Digoxin for treatment: This statement is true. Digoxin is sometimes used in the treatment of atrial fibrillation, especially when there is rate control required, particularly in patients with congestive heart failure (CHF). Digoxin helps to slow the heart rate by increasing vagal tone and inhibiting the sodium-potassium ATPase pump. Although it is not the first-line treatment for rate control (which often involves beta-blockers or calcium channel blockers), it is used in certain situations, especially in patients with concomitant heart failure. D. Aspirin in low risk patients: This statement is true, but with caveats. In patients with low risk of stroke (as determined by the CHA2DS2-VASc score), aspirin may be considered as a less potent alternative to anticoagulants, though it is no longer considered as effective in preventing stroke compared to oral anticoagulants. For low-risk patients, aspirin may still be prescribed for its antiplatelet effect, but it is usually less preferred than anticoagulants like dabigatran, rivaroxaban, or warfarin for stroke prevention in AF.",
      "correct_choice_id": 217974,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46017151700634621/46017151700634621.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46017151700634621/46017151700634621.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75706,
      "choices": [
        {
          "id": 217976,
          "text": "Amiodarone"
        },
        {
          "id": 217977,
          "text": "Lignocaine"
        },
        {
          "id": 217978,
          "text": "Quinidine"
        },
        {
          "id": 217979,
          "text": "Adenosine"
        }
      ],
      "text": "Drug of choice in PSVT is:",
      "unique_key": "Q7736256",
      "question_audio": null,
      "question_video": null,
      "map_id": 34335759,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Adenosine Explanation of the Correct Answer: The drug of choice for paroxysmal supraventricular tachycardia (PSVT) is adenosine. Adenosine works by interrupting the conduction through the AV node, which is often the site of the re-entry circuit in PSVT. This results in a temporary block of the AV node, which effectively terminates the arrhythmia. Adenosine is fast-acting and has a very short half-life, making it a first-line therapy for PSVT. It is administered as a rapid intravenous push, and its effects can be seen almost immediately. For most cases of PSVT, adenosine is effective in restoring normal sinus rhythm. Explanation of the Incorrect Responses: A. Amiodarone: Amiodarone is a class III antiarrhythmic drug that is primarily used for ventricular arrhythmias (such as ventricular tachycardia) and atrial fibrillation, especially in acute settings or when other drugs are ineffective. While amiodarone can be used for atrial arrhythmias like PSVT, it is not the first-line treatment. Its use is typically reserved for situations where adenosine is ineffective or contraindicated, as amiodarone has a longer onset and more side effects. B. Lignocaine (Lidocaine): Lidocaine is a class 1b antiarrhythmic agent primarily used for ventricular arrhythmias (e.g., ventricular tachycardia or ventricular fibrillation). It is not effective in the treatment of PSVT, which involves a re-entry mechanism in the atria and AV node. While lidocaine can suppress ectopic ventricular beats, it does not address the mechanisms of supraventricular tachycardia. Therefore, it is not the drug of choice for PSVT. C. Quinidine: Quinidine is a class 1a antiarrhythmic drug used to treat atrial and ventricular arrhythmias, including atrial fibrillation and atrial flutter. However, quinidine has several side effects (such as QT prolongation and digoxin toxicity) and is not commonly used in the acute management of PSVT. Adenosine is preferred because of its rapid onset and ability to terminate PSVT with minimal side effects.",
      "correct_choice_id": 217979,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51412401700634631/51412401700634631.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51412401700634631/51412401700634631.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75707,
      "choices": [
        {
          "id": 217980,
          "text": "Amiodarone"
        },
        {
          "id": 217981,
          "text": "Lignocaine"
        },
        {
          "id": 217982,
          "text": "Verapamil"
        },
        {
          "id": 217983,
          "text": "Adenosine"
        }
      ],
      "text": "Drug of choice for maintenance therapy in PSVT is",
      "unique_key": "Q5871268",
      "question_audio": null,
      "question_video": null,
      "map_id": 34164003,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Verapamil Explanation of the Correct Answer: For maintenance therapy in PSVT (paroxysmal supraventricular tachycardia), the most effective drug is verapamil, a calcium channel blocker. Verapamil works by blocking calcium influx into cardiac cells, particularly in the AV node, which plays a central role in the re-entry circuits that cause PSVT. By slowing the conduction through the AV node, verapamil prevents further episodes of PSVT and helps maintain normal sinus rhythm. It is a first-line agent for long-term management of PSVT, particularly in patients who experience recurrent episodes. Explanation of the Incorrect Responses: A. Amiodarone: Amiodarone is a class III antiarrhythmic used for the treatment of ventricular arrhythmias and atrial fibrillation, but it is not typically used for PSVT maintenance. It can be used for atrial arrhythmias, especially if the arrhythmia is persistent or complicated, but because of its side effect profile (including thyroid, pulmonary, and liver toxicity) and its slower onset of action, it is not the drug of choice for long-term management of PSVT. B. Lignocaine (Lidocaine): Lidocaine is a class 1b antiarrhythmic primarily used for ventricular arrhythmias, particularly ventricular tachycardia or ventricular fibrillation. It is not effective in the maintenance of PSVT, as PSVT involves atrial circuits that lidocaine does not target effectively. Lidocaine is typically used in the acute setting rather than for long-term management. D. Adenosine: Adenosine is the drug of choice for acute termination of PSVT because it temporarily blocks conduction through the AV node, effectively stopping the arrhythmia. However, adenosine has a very short duration of action and is not suitable for maintenance therapy. Its use is typically limited to acute episodes, not as a long-term treatment option.",
      "correct_choice_id": 217982,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/15180961700634643/15180961700634643.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/15180961700634643/15180961700634643.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75708,
      "choices": [
        {
          "id": 217984,
          "text": "QRs < 0.12 seconds"
        },
        {
          "id": 217985,
          "text": "Ventricular rate > 100/min"
        },
        {
          "id": 217986,
          "text": "Variable first heart sound"
        },
        {
          "id": 217987,
          "text": "Relieved by carotid sinus massage"
        }
      ],
      "text": "All of the following features can differentiate supraventricular tachycardia from ventricular tachycardia except:",
      "unique_key": "Q4557569",
      "question_audio": null,
      "question_video": null,
      "map_id": 34743063,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Ventricular rate > 100/min Explanation of the Correct Answer: A ventricular rate > 100/min is not a distinguishing factor between ventricular tachycardia (VT) and supraventricular tachycardia (SVT), as both arrhythmias can have a ventricular rate greater than 100/min. While a high heart rate is a characteristic of both, the ventricular rate alone does not provide enough information to differentiate between VT and SVT. This is why ventricular rate > 100/min is not a reliable feature to make a distinction between the two arrhythmias. Explanation of the Incorrect Responses: A. QRs < 0.14 seconds: In VT, the QRS complex is typically wide, often greater than 0.14 seconds, because the impulse originates in the ventricles, causing a delayed ventricular depolarization. In SVT, the QRS complex is usually narrow (< 0.14 seconds) because the impulse originates from above the ventricles, and the ventricles are activated normally. Therefore, the duration of the QRS complex is an important distinguishing feature, making this an effective way to differentiate between VT and SVT. C. Variable first heart sound: In ventricular tachycardia, there is often variable timing of the first heart sound (S1) because the ventricular contraction occurs at different intervals due to the abnormal electrical activity. This variation in S1 timing is a feature of VT that distinguishes it from SVT, where the first heart sound is usually more consistent because the atrial and ventricular contractions are synchronized in SVT. D. Relieved by carotid sinus massage: Carotid sinus massage is an effective maneuver to terminate supraventricular tachycardia (SVT), especially those that involve a re-entry circuit in the AV node, as it increases parasympathetic tone and slows AV conduction. However, carotid sinus massage is typically ineffective in ventricular tachycardia because VT is caused by abnormal ventricular electrical activity, which does not respond to vagal stimulation. Therefore, the response to carotid sinus massage is a key differentiating feature between VT and SVT.",
      "correct_choice_id": 217985,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13703021700634659/13703021700634659.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13703021700634659/13703021700634659.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75709,
      "choices": [
        {
          "id": 217988,
          "text": "Dilated cardiomyopathy"
        },
        {
          "id": 217989,
          "text": "Myocardial Reperfusion"
        },
        {
          "id": 217990,
          "text": "Digitalis Intoxication"
        },
        {
          "id": 217991,
          "text": "Myocarditis"
        }
      ],
      "text": "Accelerated Idioventricular Rhythm (AIVR) is the most common arrhythmia associated with:",
      "unique_key": "Q1352464",
      "question_audio": null,
      "question_video": null,
      "map_id": 34879105,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Myocardial Reperfusion Explanation of the Correct Answer: Accelerated Idioventricular Rhythm (AIVR) is most commonly associated with myocardial reperfusion, especially after interventions like thrombolysis or percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (MI). AIVR occurs as a result of reperfusion of the ischemic myocardium. When blood flow is restored to previously ischemic areas, it can lead to electrical instability in the ventricles, triggering idioventricular rhythms. AIVR is often seen as a benign arrhythmia in this context and usually resolves without treatment, making it a common and expected finding after reperfusion therapies. Explanation of the Incorrect Responses: A. Dilated Cardiomyopathy: In dilated cardiomyopathy (DCM), the heart muscle is weakened and dilated, which can lead to a variety of arrhythmias, including ventricular tachycardia or atrial fibrillation. However, AIVR is not specifically characteristic of DCM. While arrhythmias are common in DCM, AIVR is more strongly associated with myocardial reperfusion rather than the chronic structural changes seen in DCM. C. Digitalis Intoxication: Digitalis intoxication can lead to a variety of arrhythmias, such as atrial tachycardia with block, ventricular arrhythmias, or bradycardia. However, AIVR is not typically seen in the context of digitalis toxicity. Instead, digitalis toxicity usually results in arrhythmias due to its effect on the conduction system, particularly in the atria and AV node, rather than idioventricular rhythms. D. Myocarditis: In myocarditis, inflammation of the heart muscle can lead to a variety of arrhythmias, including ventricular tachycardia or atrial fibrillation, but AIVR is not the most common arrhythmia associated with myocarditis. The arrhythmias in myocarditis are typically more varied and linked to the underlying inflammation and damage to the conduction system, rather than being specifically associated with AIVR.",
      "correct_choice_id": 217989,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21291571700634671/21291571700634671.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21291571700634671/21291571700634671.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75710,
      "choices": [
        {
          "id": 217992,
          "text": "Hypermagnesemia"
        },
        {
          "id": 217993,
          "text": "Metabolic acidosis"
        },
        {
          "id": 217994,
          "text": "Hypomagnesmia"
        },
        {
          "id": 217995,
          "text": "Metabolic alkalosis"
        }
      ],
      "text": "Torsade-de-pointes is caused by-",
      "unique_key": "Q6780085",
      "question_audio": null,
      "question_video": null,
      "map_id": 34914406,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hypomagnesemia Explanation of the Correct Answer: Torsade-de-pointes is a type of polymorphic ventricular tachycardia characterized by a distinctive twisting of the points on the electrocardiogram (ECG). It is commonly associated with prolonged QT interval and can be precipitated by various electrolyte disturbances, most notably hypomagnesemia (low levels of magnesium in the blood). Magnesium is crucial for the normal function of the heart's electrical system, and low magnesium levels can lead to QT prolongation, which predisposes to the development of Torsade-de-pointes. Magnesium plays a role in stabilizing the cardiac cell membrane, and its deficiency can lead to reentrant arrhythmias like Torsade-de-pointes. Explanation of the Incorrect Responses: A. Hypermagnesemia: Hypermagnesemia (elevated magnesium levels) is not typically associated with Torsade-de-pointes. In fact, high magnesium levels may prevent arrhythmias by stabilizing the cardiac membrane. While extremely high levels of magnesium can lead to bradycardia or heart block, it does not typically trigger Torsade-de-pointes. B. Metabolic Acidosis: Metabolic acidosis refers to a decrease in blood pH, which can affect the heart's electrical stability. While acidosis can lead to arrhythmias, it is not a common direct cause of Torsade-de-pointes. The primary arrhythmia associated with metabolic acidosis is sinus tachycardia or other ventricular arrhythmias, but hypomagnesemia is a far more common cause of Torsade-de-pointes than acidosis. D. Metabolic Alkalosis: Metabolic alkalosis (increased blood pH) can also affect the heart's electrical conduction, but it is typically associated with other arrhythmias such as atrial tachycardia. While alkalosis can potentially contribute to prolonged QT intervals and arrhythmias, it is hypomagnesemia that is more directly linked to Torsade-de-pointes.",
      "correct_choice_id": 217994,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22903361700634683/22903361700634683.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22903361700634683/22903361700634683.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75711,
      "choices": [
        {
          "id": 217996,
          "text": "Left free wall"
        },
        {
          "id": 217997,
          "text": "Posteroseptal"
        },
        {
          "id": 217998,
          "text": "Right free wall"
        },
        {
          "id": 217999,
          "text": "Anteroseptal"
        }
      ],
      "text": "The most common accessory pathways leading to WPW syndrome is:",
      "unique_key": "Q5740482",
      "question_audio": null,
      "question_video": null,
      "map_id": 34150469,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Left Free Wall Explanation of the Correct Answer: The most common accessory pathway in Wolff-Parkinson-White (WPW) syndrome is located on the left free wall of the heart. In WPW syndrome, there is an abnormal accessory conduction pathway (often referred to as a Bundle of Kent) that allows electrical signals to bypass the normal conduction system (i.e., the AV node) and travel directly from the atria to the ventricles. This leads to a pre-excitation of the ventricles. The left free wall pathway is the most frequent location for these abnormal pathways, which can result in a shortened PR interval and delta waves on the ECG, hallmark signs of WPW syndrome. Explanation of the Incorrect Responses: B. Posteroseptal: The posteroseptal location for the accessory pathway is not the most common site in WPW syndrome. While accessory pathways can be located in the posteroseptal region, they are relatively less frequent compared to the left free wall pathway. Posteroseptal pathways are more likely to cause arrhythmias like atrioventricular reentrant tachycardia (AVRT) but are not the most typical pathway seen in WPW syndrome. C. Right Free Wall: While accessory pathways can be found in the right free wall, this location is less common in WPW syndrome compared to the left free wall pathway. Accessory pathways on the right side of the heart are generally associated with right-sided pre-excitation but are less frequent than those on the left side. D. Anteroseptal: The anteroseptal pathway is also a possible site for an accessory pathway in WPW syndrome, but it is not as common as the left free wall pathway. The anteroseptal location might be seen in certain cases of WPW but does not represent the most frequent site of the accessory pathway.",
      "correct_choice_id": 217996,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27932711700634696/27932711700634696.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27932711700634696/27932711700634696.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75712,
      "choices": [
        {
          "id": 218000,
          "text": "Orthodromic AV re-entry"
        },
        {
          "id": 218001,
          "text": "Antidromic AV re-entry"
        },
        {
          "id": 218002,
          "text": "Rapidly conducting AF"
        },
        {
          "id": 218003,
          "text": "Ventricular tachycardia"
        }
      ],
      "text": "The most common re-entrant tachycardia associated with WPW syndrome is",
      "unique_key": "Q8122206",
      "question_audio": null,
      "question_video": null,
      "map_id": 34742736,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Orthodromic AV re-entry Explanation of the Correct Answer: The most common re-entrant tachycardia associated with WPW syndrome is orthodromic atrioventricular (AV) re-entry tachycardia (AVRT). In orthodromic AVRT, the electrical impulse travels down the normal AV node and then retrogradely up the accessory pathway (the Bundle of Kent). This results in a narrow QRS complex tachycardia due to the normal direction of conduction through the ventricles. Orthodromic AVRT is the most frequent form of arrhythmia seen in WPW syndrome and is typically well-tolerated by patients. Explanation of the Incorrect Responses: B. Antidromic AV re-entry: Antidromic AVRT is another form of re-entrant tachycardia seen in WPW syndrome, but it is less common than orthodromic AVRT. In antidromic AVRT, the electrical impulse travels down the accessory pathway and then retrogradely up the normal AV node. This results in a wide QRS complex tachycardia due to the abnormal direction of conduction through the ventricles. While antidromic AVRT can occur in WPW, it is much less frequent than orthodromic AVRT. C. Rapidly conducting AF (Atrial Fibrillation): While atrial fibrillation (AF) can occur in individuals with WPW syndrome, it is not the most common re-entrant tachycardia associated with the condition. Rapidly conducting AF can be dangerous in WPW because the accessory pathway allows rapid conduction from the atria to the ventricles, potentially leading to ventricular fibrillation. However, this is an emergency situation and does not occur as frequently as orthodromic AVRT. D. Ventricular tachycardia: Ventricular tachycardia (VT) is not typically associated with WPW syndrome. Although VT can occur in certain conditions, it is not the primary arrhythmia in WPW. The most common re-entrant tachycardia in WPW is orthodromic AVRT, as previously explained. Ventricular tachycardia generally arises from other conditions such as structural heart disease, and it is less likely to be directly related to WPW syndrome.",
      "correct_choice_id": 218000,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16711281700634710/16711281700634710.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16711281700634710/16711281700634710.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75713,
      "choices": [
        {
          "id": 218004,
          "text": "More common in females"
        },
        {
          "id": 218005,
          "text": "Lt ventricular aberrant is commonly seen"
        },
        {
          "id": 218006,
          "text": "Prevalence decreased with age"
        },
        {
          "id": 218007,
          "text": "Heart is structurally normal"
        }
      ],
      "text": "All of the following statements about WPW syndrome are true, Except:",
      "unique_key": "Q5838638",
      "question_audio": null,
      "question_video": null,
      "map_id": 34274674,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) More common in females Explanation of the Correct Answer: WPW syndrome is actually more common in males than in females. It is a congenital condition that results in an accessory pathway allowing electrical impulses to bypass the normal route through the AV node, which can lead to re-entrant tachycardias such as orthodromic and antidromic AVRT. While the syndrome occurs in both genders, the prevalence is higher in males, not females. This makes statement A incorrect. Explanation of the Incorrect Responses: B. Left ventricular aberrant conduction is commonly seen: Left ventricular aberrant conduction (abnormal conduction patterns in the left ventricle) is indeed commonly observed in WPW syndrome. The accessory pathway often connects the atria to the ventricles, and when it does so in the left side, it leads to conduction abnormalities in the left ventricle. This can contribute to the wide QRS complexes and the typical arrhythmias seen in WPW. C. Prevalence increases with age: This statement is incorrect. The prevalence of WPW syndrome is not associated with increasing age. WPW is a congenital condition, and the symptoms typically become evident in young adults or in early adulthood. However, the clinical expression of WPW, such as arrhythmias, might manifest more in some individuals as they age, but the condition itself does not increase with age. D. The heart is structurally normal: In most cases of WPW syndrome, the heart is structurally normal, with no underlying cardiomyopathy or other structural heart abnormalities. The condition arises from the presence of an extra electrical pathway, and the anatomy of the heart is typically normal, which makes statement D true. The heart's structural normality distinguishes WPW from other arrhythmogenic conditions caused by structural heart disease.",
      "correct_choice_id": 218004,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24324471700634727/24324471700634727.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24324471700634727/24324471700634727.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75714,
      "choices": [
        {
          "id": 218008,
          "text": "Verapamil"
        },
        {
          "id": 218009,
          "text": "Procainamide"
        },
        {
          "id": 218010,
          "text": "Ibutilide"
        },
        {
          "id": 218011,
          "text": "Amiodarone"
        }
      ],
      "text": "A patient with short PR interval and Delta waves on ECG presents to the emergency department with Atrial Fibrillation and rapid ventricular rate. He is hemodynamically stable. All of the following agents may be used in the management, except:",
      "unique_key": "Q5082768",
      "question_audio": null,
      "question_video": null,
      "map_id": 34267190,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Verapamil Explanation of the Correct Answer: In patients with WPW syndrome (as suggested by the presence of short PR interval and Delta waves on ECG), the use of Verapamil is contraindicated in the setting of Atrial Fibrillation (AF) with a rapid ventricular response. This is because Verapamil, a calcium channel blocker, can block the AV node, but in WPW syndrome, there is an accessory pathway (the bundle of Kent) that bypasses the AV node. If Verapamil is used, it can result in uncontrolled conduction through the accessory pathway, leading to ventricular fibrillation (VF) or other life-threatening arrhythmias due to pre-excitation. Therefore, Verapamil should be avoided in such cases. Explanation of the Incorrect Responses: B. Procainamide: Procainamide is a class 1A antiarrhythmic that is safe and can be used in WPW syndrome with AF to control the ventricular rate. It works by blocking sodium channels and can interrupt the re-entry circuit in the accessory pathway. Procainamide is a reasonable choice for rate control and rhythm conversion in patients with WPW and AF. C. Ibutilide: Ibutilide is a class III antiarrhythmic drug used for pharmacologic cardioversion of AF or atrial flutter. It is effective in converting AF to sinus rhythm and can be safely used in patients with WPW syndrome when trying to restore normal rhythm. Although it carries a risk of proarrhythmia, it is considered a good option for rhythm control in patients with AF and WPW syndrome. D. Amiodarone: Amiodarone is a broad-spectrum antiarrhythmic that can be used for rate control and rhythm conversion in patients with WPW syndrome and AF. It works by affecting multiple ion channels, and is effective in stabilizing the arrhythmia and reducing the risk of rapid conduction through the accessory pathway. In hemodynamically stable patients, Amiodarone is a reasonable choice for rhythm control.",
      "correct_choice_id": 218008,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6335951700634738/6335951700634738.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6335951700634738/6335951700634738.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75715,
      "choices": [
        {
          "id": 218012,
          "text": "Constant PR interval"
        },
        {
          "id": 218013,
          "text": "Normal QRS morphology"
        },
        {
          "id": 218014,
          "text": "Regular Atrial Rhythm"
        },
        {
          "id": 218015,
          "text": "Atrial rate > ventricular rate"
        }
      ],
      "text": "All of the following are feature of Mobitz Type I block, except:",
      "unique_key": "Q4847561",
      "question_audio": null,
      "question_video": null,
      "map_id": 34528466,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Constant PR interval Explanation of the Correct Answer: In Mobitz Type I (also known as Wenckebach) second-degree atrioventricular (AV) block, the key feature is that the PR interval progressively lengthens with each successive beat until a beat is dropped (i.e., a QRS complex is not conducted). Therefore, the PR interval is not constant in this type of block. The characteristic progressive PR interval prolongation before a dropped beat is the hallmark of Mobitz Type I block, making A. Constant PR interval an incorrect choice. Explanation of the Incorrect Responses: B. Normal QRS morphology: In Mobitz Type I block, the QRS complex is typically normal in morphology unless there is an underlying bundle branch block. The atrial impulses are still conducted to the ventricles, but only intermittently due to the progressive AV nodal block. Thus, normal QRS morphology is a typical feature in Mobitz Type I block. C. Regular Atrial Rhythm: The atrial rhythm in Mobitz Type I block is usually regular because the atrial impulses are unaffected by the block. The issue is in the AV node's ability to conduct some impulses to the ventricles. As a result, the atrial rate remains regular, while the ventricular rate may become irregular due to the intermittent conduction of impulses through the AV node. D. Atrial rate > Ventricular rate: In Mobitz Type I block, the atrial rate is often higher than the ventricular rate because, with each progressive delay in conduction through the AV node, only some atrial impulses are transmitted to the ventricles. As a result, there are more atrial beats than ventricular beats, leading to Atrial rate > Ventricular rate. This is a common finding in Mobitz Type I block.",
      "correct_choice_id": 218012,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22076861700634750/22076861700634750.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22076861700634750/22076861700634750.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75716,
      "choices": [
        {
          "id": 218016,
          "text": "Normal QRS complex morphology"
        },
        {
          "id": 218017,
          "text": "Atrial rate more than ventricular rate"
        },
        {
          "id": 218018,
          "text": "Constant PR interval"
        },
        {
          "id": 218019,
          "text": "No constant Relationship between P wave and QRS complex"
        }
      ],
      "text": "All of the following may be seen in Mobitz Type II second degree Heart block, except:",
      "unique_key": "Q7334962",
      "question_audio": null,
      "question_video": null,
      "map_id": 34515935,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) No constant relationship between P wave and QRS complex Explanation of the Correct Answer: In Mobitz Type II second-degree heart block, there is a constant relationship between the P wave and the QRS complex. In this type of block, some atrial impulses (P waves) are not conducted to the ventricles, but the conduction is consistent when it occurs. This means that after a certain number of conducted beats (for example, 2:1 or 3:1 conduction), the next P wave is blocked, but the pattern is regular and predictable. Therefore, there is a constant relationship between the P waves and QRS complexes, making D. No constant relationship between P wave and QRS complex an incorrect statement for Mobitz Type II. Explanation of the Incorrect Responses: A. Normal QRS complex morphology: In Mobitz Type II block, the QRS complex is often normal unless there is a bundle branch block. However, because Mobitz Type II block typically involves a problem in the His-Purkinje system, the conduction abnormality is more likely to result in non-conducted P waves rather than changes in the QRS morphology. So, normal QRS complex morphology is commonly seen in Mobitz Type II. B. Atrial rate more than ventricular rate: In Mobitz Type II block, the atrial rate is usually higher than the ventricular rate, similar to Mobitz Type I block. This occurs because the atria continue to generate regular impulses, but only some are conducted through the AV node, resulting in fewer ventricular beats. Therefore, atrial rate > ventricular rate is a typical feature of Mobitz Type II. C. Constant PR interval: In Mobitz Type II block, the PR interval is constant in those beats that are conducted. Unlike Mobitz Type I, where the PR interval gradually lengthens before a dropped beat, in Mobitz Type II, the PR interval remains fixed for every conducted beat. This is an important distinguishing feature of Mobitz Type II.",
      "correct_choice_id": 218019,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37359101700634761/37359101700634761.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37359101700634761/37359101700634761.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75717,
      "choices": [
        {
          "id": 218020,
          "text": "Atropine"
        },
        {
          "id": 218021,
          "text": "Pacing"
        },
        {
          "id": 218022,
          "text": "Isoproterenol"
        },
        {
          "id": 218023,
          "text": "Diltiazem"
        }
      ],
      "text": "In the treatment of severe bradycardia, all of the following can be the best modality of treatment except:",
      "unique_key": "Q2011894",
      "question_audio": null,
      "question_video": null,
      "map_id": 34404641,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Diltiazem Explanation of the Correct Answer: Diltiazem is a calcium channel blocker, and it slows the heart rate by inhibiting the flow of calcium ions into the cardiac muscle and conduction system. It is typically used to manage conditions like atrial fibrillation or supraventricular tachycardia by controlling the rate of the atrial impulses conducted through the AV node. However, it should not be used in the treatment of severe bradycardia because it can further slow the heart rate, potentially leading to cardiac arrest in some cases. In severe bradycardia, it is essential to increase the heart rate, and diltiazem works contrary to this goal. Thus, Diltiazem is not appropriate for treating severe bradycardia. Explanation of the Incorrect Responses: A. Atropine: Atropine is the first-line treatment for severe bradycardia. It is an anticholinergic drug that works by blocking the parasympathetic influence on the heart, leading to increased heart rate. It is commonly used in symptomatic bradycardia to increase the heart rate by inhibiting vagal stimulation. Atropine is one of the most effective and widely used drugs in the acute management of severe bradycardia, making it an appropriate modality of treatment. B. Pacing: Pacing, specifically transcutaneous pacing or transvenous pacing, is another effective option for managing severe bradycardia. In situations where pharmacological treatment (such as atropine) is not effective, pacing can provide a temporary or permanent electrical stimulus to the heart, ensuring that it beats at an adequate rate. This is especially important in cases of third-degree heart block or other forms of bradycardia where the heart's electrical conduction system is severely impaired. C. Isoproterenol: Isoproterenol is a beta-adrenergic agonist that can increase heart rate by stimulating beta-1 receptors in the heart. It is often used in cases of severe bradycardia when atropine and pacing are not sufficient or appropriate. It is especially useful in cases of bradycardia caused by heart block or sick sinus syndrome. Isoproterenol helps to stimulate the heart's natural pacemaker cells and improve conduction through the AV node, making it a good option for increasing heart rate in cases of severe bradycardia.",
      "correct_choice_id": 218023,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28083001700634772/28083001700634772.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28083001700634772/28083001700634772.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75718,
      "choices": [
        {
          "id": 218024,
          "text": "Sinus tachycardia"
        },
        {
          "id": 218025,
          "text": "Atrial fibrillation"
        },
        {
          "id": 218026,
          "text": "PSVT"
        },
        {
          "id": 218027,
          "text": "Atrial flutter"
        }
      ],
      "text": "A 42-year-old comes to the ED with c/o palpitations and fluttering in his chest. He has never had this before. He denies chest pain, light headedness, or shortness of breath. He is very anxious. He drinks alcohol four to five times a week. O/E- Respiratory rate: 32 breaths/minute; BP: 118/88 mm Hg; Pulse:128 beats/minute, irregularly irregular with positive pulse deficit. What is the likely cause of patients tachycardia?",
      "unique_key": "Q6923455",
      "question_audio": null,
      "question_video": null,
      "map_id": 34757405,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Atrial fibrillation. This patient presents with palpitations, irregularly irregular pulse, and positive pulse deficit. The term \"irregularly irregular\" is characteristic of atrial fibrillation (AF), which is the most likely cause of the patient's tachycardia. AF is the most common arrhythmia and typically presents with an irregularly irregular rhythm on palpation of the pulse, as seen in this case. In AF, the atria quiver rather than contracting effectively, which leads to an irregular ventricular response. The pulse deficit (the difference between the auscultated heart rate and the palpated pulse rate) is also common in AF due to the absence of coordinated atrial contraction. The patient's anxiety, alcohol use, and absence of other symptoms like chest pain or shortness of breath make AF the most likely diagnosis in this case. The other options are incorrect for the following reasons: (A) Sinus tachycardia: Sinus tachycardia is characterized by a regular tachycardic rhythm (elevated heart rate), typically above 100 beats per minute but with normal sinus rhythm. The patients irregularly irregular pulse and positive pulse deficit do not fit the description of sinus tachycardia, which has a regular rhythm. Sinus tachycardia is usually associated with triggers like fever, hypovolemia, or stress, none of which are present here. (C) PSVT (Paroxysmal Supraventricular Tachycardia): PSVT is typically a regular tachycardia with sudden onset and termination. The rhythm is usually regular, with a rate that can exceed 150 beats per minute. This patient's irregularly irregular pulse is inconsistent with PSVT, which typically presents with a regular rhythm. (D) Atrial flutter: Atrial flutter is characterized by a regular atrial rhythm, typically around 250350 beats per minute, with a sawtooth pattern on the ECG. While atrial flutter can lead to a rapid ventricular response, the pulse would generally be regular rather than irregularly irregular. In this case, the patients irregularly irregular pulse and pulse deficit suggest atrial fibrillation rather than atrial flutter.",
      "correct_choice_id": 218025,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4354031705729356/4354031705729356.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4354031705729356/4354031705729356.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75719,
      "choices": [
        {
          "id": 218028,
          "text": "Palpitations not improved with medication"
        },
        {
          "id": 218029,
          "text": "Severe anxiety"
        },
        {
          "id": 218030,
          "text": "Palpitations"
        },
        {
          "id": 218031,
          "text": "BP 78/50 mm Hg and chest pain"
        }
      ],
      "text": "A 30-year-old patient k/c/o RHD with mitral stenosis presented with palpitations for 2 days along with sweating. Pulse rate is 140/min, pulse deficit of 15 is present with irregular rhythm. ECG revealed atrial fibrillation. When is immediate electrical cardioversion needed in this patient?",
      "unique_key": "Q7557555",
      "question_audio": null,
      "question_video": null,
      "map_id": 34950487,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) BP 78/50 mm Hg and chest pain. In this patient with rheumatic heart disease (RHD) and mitral stenosis who develops atrial fibrillation (AF), immediate electrical cardioversion is indicated in cases where there is hemodynamic instability, which is manifested by hypotension (BP of 78/50 mm Hg) and chest pain. These are signs of acute heart failure or ischemia, potentially related to a rapid ventricular response in AF. When the patient is unstable and there is evidence of poor perfusion (low BP) and possible myocardial ischemia (chest pain), immediate cardioversion is required to restore normal rhythm and improve circulation. The other options are incorrect for the following reasons: (A) Palpitations not improved with medication: While palpitations may be bothersome and warrant treatment, palpitations alone, even if they do not improve with medication, do not justify immediate electrical cardioversion. The need for cardioversion is more urgent in the context of hemodynamic instability or other severe symptoms such as chest pain or syncope. (B) Severe anxiety: Anxiety can often exacerbate the perception of palpitations, but it is not a life-threatening complication. It does not require immediate cardioversion unless it is accompanied by other more concerning symptoms such as hypotension or chest pain. Treating anxiety with appropriate medication or reassurance is typically the first step, and immediate cardioversion is not indicated. (C) Palpitations: Palpitations alone, even if uncomfortable, do not warrant immediate cardioversion unless the patient is hemodynamically unstable. In most cases, AF with palpitations can be managed with rate control or rhythm control medication and does not require urgent electrical cardioversion unless the patient shows signs of hemodynamic compromise.",
      "correct_choice_id": 218031,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6438001705729370/6438001705729370.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6438001705729370/6438001705729370.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75720,
      "choices": [
        {
          "id": 218032,
          "text": "Caffeine"
        },
        {
          "id": 218033,
          "text": "Coronary artery disease"
        },
        {
          "id": 218034,
          "text": "Hypertension"
        },
        {
          "id": 218035,
          "text": "Hyperthyroidism"
        }
      ],
      "text": "A 45 year old male known case of hypertension on amlodipine presented with palpitations with dyspnea. On examination-pulse rate is 180/min, irregularly irregular rhythm with pulse deficit of 20. No cardiac murmur is found.BP-120/80 mmHg. He is a smoker and takes 4-5 cups of strong coffee daily. ECG done is shown in the figure. What is the most common cause of this arrythmia?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/5(317).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2399677",
      "question_audio": null,
      "question_video": null,
      "map_id": 34713626,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hypertension. This patient is presenting with palpitations, dyspnea, a pulse rate of 180/min, and an irregularly irregular rhythm with a pulse deficit of 20, which suggests atrial fibrillation (AF). Hypertension is one of the most common causes of AF, especially in patients who have been hypertensive for a long period, leading to left atrial enlargement and changes in the atrial electrical conduction system, which predispose to the development of atrial fibrillation. Given that the patient is already known to have hypertension, this is likely the underlying cause of his AF. The ECG findings likely show AF with a rapid ventricular response, which is often seen in patients with chronic hypertension. The other options are incorrect for the following reasons: (A) Caffeine: While caffeine can increase heart rate and potentially provoke arrhythmias in susceptible individuals, it is not the most common cause of AF. In this patient, the long-standing hypertension is a more likely underlying cause for the arrhythmia, and caffeine's effect is usually transient and less likely to cause sustained arrhythmias like AF in the absence of other structural heart disease. (B) Coronary artery disease (CAD): CAD can lead to arrhythmias, particularly if there is myocardial ischemia or heart failure. However, in this patient, there is no mention of chest pain, history of myocardial infarction, or other signs of ischemia. The patients normal blood pressure (120/80 mm Hg) and absence of a cardiac murmur suggest there is no acute ischemic event, making CAD a less likely cause of his AF. (D) Hyperthyroidism: Hyperthyroidism can cause arrhythmias, particularly atrial fibrillation, due to increased metabolic demand and the effects of thyroid hormones on the heart. However, this patient does not have the typical symptoms of hyperthyroidism, such as weight loss, heat intolerance, or tremors. Additionally, hyperthyroidism is not the most common cause of AF, especially in the absence of other suggestive signs or symptoms.",
      "correct_choice_id": 218034,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17869251705729392/17869251705729392.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17869251705729392/17869251705729392.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75721,
      "choices": [
        {
          "id": 218036,
          "text": "Quinidine"
        },
        {
          "id": 218037,
          "text": "Heparin"
        },
        {
          "id": 218038,
          "text": "Warfarin"
        },
        {
          "id": 218039,
          "text": "Metoprolol"
        }
      ],
      "text": "In continuation with previous clinical vignette the patient is uncomfortable from palpitations but is hemodynamically stable. What is the next appropriate treatment?",
      "unique_key": "Q2246589",
      "question_audio": null,
      "question_video": null,
      "map_id": 34970905,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Metoprolol. In this patient with atrial fibrillation (AF) who is hemodynamically stable but experiencing palpitations, the next appropriate treatment is rate control to manage the rapid heart rate and relieve symptoms like palpitations. Metoprolol, a beta-blocker, is commonly used to slow the ventricular rate in AF, especially when the patient is stable. Beta-blockers work by blocking the effects of sympathetic stimulation on the heart, resulting in decreased heart rate and improved control of symptoms. This is the first-line therapy for rate control in patients with AF who are stable and not showing signs of heart failure or severe symptoms. The other options are incorrect for the following reasons: (A) Quinidine: Quinidine is an antiarrhythmic drug used for rhythm control, not for rate control. Rhythm control is typically considered in patients with symptomatic AF, but since this patient is hemodynamically stable and the priority is to manage his rate and symptoms of palpitations, quinidine is not the immediate choice. Rate control should be addressed first in most cases of stable AF. (B) Heparin: Heparin is an anticoagulant used for acute anticoagulation, especially in cases where there is a high risk of thromboembolism, such as when AF is of recent onset or when a patient has other risk factors for clot formation. However, this patient is not acutely at risk for embolism or stroke, as the vignette does not mention recent onset of AF, clot risk factors, or need for immediate anticoagulation. The primary concern at this time is rate control, not anticoagulation. (C) Warfarin: Warfarin is another anticoagulant that is used to prevent stroke in patients with AF who are at high risk of thromboembolism. However, the initial management of a patient who is hemodynamically stable and experiencing palpitations focuses on controlling the heart rate, not starting anticoagulation right away. Anticoagulation may be considered later based on the patient's stroke risk factors (e.g., CHA2DS2-VASc score) but is not the immediate treatment in a stable patient with no evidence of acute thromboembolic risk.",
      "correct_choice_id": 218039,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18661701705729406/18661701705729406.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18661701705729406/18661701705729406.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75722,
      "choices": [
        {
          "id": 218040,
          "text": "Aspirin"
        },
        {
          "id": 218041,
          "text": "Warfarin"
        },
        {
          "id": 218042,
          "text": "Dabigatran"
        },
        {
          "id": 218043,
          "text": "Rivaroxaban"
        }
      ],
      "text": "In previous clinical case after metoprolol , the patients heart rate reduces to 80 beats/minute. All symptoms resolve. The patient is placed on a regular hospital ward. The echocardiogram shows a normal heart size and shape with no significant valvular disease and no thrombi. The AF does not stop, but the rate remains controlled and there are no symptoms What is the best therapy?",
      "unique_key": "Q1985990",
      "question_audio": null,
      "question_video": null,
      "map_id": 34079748,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Aspirin. In this patient with atrial fibrillation (AF), who has controlled heart rate, is symptom-free, and has a normal echocardiogram with no valvular abnormalities or thrombi, the decision for long-term antithrombotic therapy is based on the stroke risk assessed by the CHA2DS2-VASc score. A young patient without significant risk factors for stroke (e.g., no history of heart failure, hypertension, age 65, diabetes, or prior thromboembolism) can be managed with aspirin as a preventive measure for stroke. This is because their stroke risk is low, and the risk-benefit ratio of stronger anticoagulants does not favor their use in such cases. Reasons for Incorrect Options: (B) Warfarin: Warfarin is an anticoagulant that is indicated for patients with AF who have a higher stroke risk, typically assessed by a CHA2DS2-VASc score 2. In this case, the patient likely has a low score, so the risk of bleeding from warfarin outweighs the potential benefit. Warfarin would be appropriate for patients with moderate to high stroke risk, those with valvular AF, or those who cannot use newer oral anticoagulants. (C) Dabigatran: Dabigatran is a direct thrombin inhibitor and one of the novel oral anticoagulants (NOACs) used for stroke prevention in AF patients with non-valvular AF and a moderate to high risk of thromboembolism (CHA2DS2-VASc score 2). This patient has a low stroke risk, so the stronger anticoagulant action of dabigatran is not justified. (D) Rivaroxaban: Like dabigatran, rivaroxaban is another NOAC used for patients with non-valvular AF who have moderate to high stroke risk. While effective, it is not necessary for patients with a low stroke risk like this one. Aspirin is sufficient in this context.",
      "correct_choice_id": 218040,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34991705729421/34991705729421.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34991705729421/34991705729421.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75723,
      "choices": [
        {
          "id": 218044,
          "text": "A Fibrillation"
        },
        {
          "id": 218045,
          "text": "Atrial flutter"
        },
        {
          "id": 218046,
          "text": "Supraventricular tachycardia"
        },
        {
          "id": 218047,
          "text": "Ventricular tachycardia"
        }
      ],
      "text": "A 29-year-old woman presents to the ED complaining of palpitations. She is anxious and her chest is uncomfortable from the rapid heart rate. She is not confused, and there is no chest pain. She is a generally healthy person, and this is the first time she has been to an ED. She drank four strong black coffee today. On examination- BP: 130/80 mm Hg; Pulse: 180 beats/minute; ECG done is shown in the figure. What is the diagnosis<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/6(284).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4428978",
      "question_audio": null,
      "question_video": null,
      "map_id": 34192214,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Supraventricular Tachycardia Supraventricular tachycardia (SVT) is a condition characterized by a rapid heart rate that originates above the ventricles in the atria or atrioventricular (AV) node. In this case, the patient's heart rate is 180 beats per minute, which is consistent with SVT. Additional supportive findings include: Symptoms: The patient reports palpitations, anxiety, and chest discomfort. These are common presentations in SVT. Triggers: High caffeine intake (four strong black coffees) can stimulate the heart and precipitate SVT by increasing sympathetic activity. ECG Findings: While the image isn't provided here, SVT typically shows a narrow QRS complex tachycardia with no discernible P waves or P waves that are difficult to identify due to rapid atrial activity. The absence of irregularity (as seen in atrial fibrillation) or flutter waves (as seen in atrial flutter) also supports the diagnosis of SVT. Stable Presentation: The patient is hemodynamically stable with normal blood pressure (130/80 mm Hg) and no confusion or significant chest pain, which fits with the typical presentation of SVT. Option A: Atrial Fibrillation Atrial fibrillation (AF) is an irregularly irregular rhythm characterized by disorganized atrial activity. ECG in AF shows: Absence of P waves. Irregular R-R intervals. Fibrillatory waves. The patient's rhythm is described as regular, which rules out AF. Additionally, AF is less commonly triggered by caffeine compared to SVT and is more common in older individuals or those with underlying cardiac conditions. Option B: Atrial Flutter Atrial flutter is characterized by a rapid atrial rate, typically around 250-350 beats per minute, with a regular ventricular response (usually in a 2:1 conduction ratio). Classic \"sawtooth\" flutter waves are visible on the ECG. In this case, no mention of flutter waves was made, and the ventricular rate of 180 bpm is more consistent with SVT rather than atrial flutter. Option D: Ventricular Tachycardia (VT) VT originates from the ventricles and is typically associated with a wide QRS complex tachycardia (>120 ms). It is more likely to occur in individuals with structural heart disease or prior myocardial infarction. The patient's ECG is described as showing a narrow QRS complex rhythm, effectively excluding VT as the diagnosis. Additionally, the patients symptoms are not severe enough to suggest VT, which often presents with hemodynamic instability.",
      "correct_choice_id": 218046,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/60427411705729434/60427411705729434.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/60427411705729434/60427411705729434.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75724,
      "choices": [
        {
          "id": 218048,
          "text": "Carotid massage"
        },
        {
          "id": 218049,
          "text": "Adenosine"
        },
        {
          "id": 218050,
          "text": "Beta blocker"
        },
        {
          "id": 218051,
          "text": "DC shock"
        }
      ],
      "text": "In continuation with previous clinical vignette patient was diagnosed as a case of PSVT. When you are checking the ECG she complaints of dyspnea and sweating and become drowsy. You check the vitals again which shows BP as 70 mmHg systolic. Chest examination revealed basal crepts. What will you do next?",
      "unique_key": "Q9288912",
      "question_audio": null,
      "question_video": null,
      "map_id": 34482862,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) DC Shock Direct current (DC) cardioversion is the treatment of choice in a patient with hemodynamic instability caused by paroxysmal supraventricular tachycardia (PSVT). In this case, the patient presents with severe hypotension (BP 70 mmHg systolic), dyspnea, sweating, drowsiness, and basal crepitations, indicating compromised cardiac output and possible pulmonary edema. These signs reflect significant hemodynamic instability, necessitating immediate synchronized cardioversion to restore sinus rhythm and improve perfusion. DC cardioversion is highly effective and rapidly terminates the arrhythmia, making it the most appropriate intervention in this critical situation. Option A: Carotid Massage Carotid sinus massage stimulates the vagus nerve and can terminate PSVT by slowing conduction through the AV node. However, it is contraindicated in hemodynamically unstable patients like this one because it is a slower and less reliable intervention in emergencies. Moreover, the patient is drowsy and showing signs of significant instability, making immediate electrical intervention essential. Option B: Adenosine Adenosine is the first-line pharmacologic treatment for stable PSVT, as it transiently blocks AV node conduction to terminate the arrhythmia. However, in an unstable patient, pharmacologic therapy is not preferred due to its slower onset compared to DC cardioversion. Delaying definitive treatment in this scenario could worsen the patient's condition. Option C: Beta Blocker Beta blockers, such as metoprolol, are used in rate control and rhythm management in stable arrhythmias. However, they are not suitable for managing acute, unstable PSVT. Beta blockers can also exacerbate hypotension and worsen hemodynamic instability, making them inappropriate for this patient.",
      "correct_choice_id": 218051,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73620521705729449/73620521705729449.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73620521705729449/73620521705729449.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75725,
      "choices": [
        {
          "id": 218052,
          "text": "Perform synchronized cardioversion."
        },
        {
          "id": 218053,
          "text": "Perform unsynchronized cardioversion."
        },
        {
          "id": 218054,
          "text": "Give amiodarone."
        },
        {
          "id": 218055,
          "text": "Give quinidine."
        }
      ],
      "text": "A patient admitted in ICU for treatment of pneumonia developed ventricular tachycardia as shown in the figure. On ECG monitor duration of ventricular tachycardia episodes was less than 30 seconds.Patients BP is 140/90 mm Hg. Palpitations are the only symptom. What should you do?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/7(254).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4500641",
      "question_audio": null,
      "question_video": null,
      "map_id": 34806825,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Give Amiodarone Amiodarone is the treatment of choice for hemodynamically stable ventricular tachycardia (VT). In this patient: The VT is non-sustained (duration <30 seconds) and the patient is hemodynamically stable with a BP of 140/90 mmHg. Amiodarone, a Class III antiarrhythmic, is effective in terminating VT and stabilizing the cardiac rhythm. It works by prolonging the action potential duration and refractory period, suppressing abnormal electrical activity. Since the patient has only palpitations without significant symptoms or signs of instability, pharmacologic treatment with amiodarone is preferred over electrical cardioversion. Option A: Perform Synchronized Cardioversion Synchronized cardioversion is indicated for hemodynamically unstable VT or when pharmacologic therapy fails in symptomatic patients. This patient is stable (normal BP, no altered mental status, or chest pain). Thus, electrical cardioversion is not necessary at this stage. Option B: Perform Unsynchronized Cardioversion Unsynchronized (defibrillation) cardioversion is used for pulseless VT or ventricular fibrillation, which are life-threatening emergencies. In this case, the patient has a palpable pulse, is hemodynamically stable, and does not require defibrillation. Option D: Give Quinidine Quinidine, a Class IA antiarrhythmic, is rarely used due to its proarrhythmic potential, including torsades de pointes, and its side effect profile. Safer and more effective options, such as amiodarone, are preferred for VT management.",
      "correct_choice_id": 218054,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4987181705729465/4987181705729465.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4987181705729465/4987181705729465.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75726,
      "choices": [
        {
          "id": 218056,
          "text": "Dilated cardiomyopathy"
        },
        {
          "id": 218057,
          "text": "Hypertrophic cardiomyopathy"
        },
        {
          "id": 218058,
          "text": "WPW syndrome"
        },
        {
          "id": 218059,
          "text": "Brugada syndrome"
        }
      ],
      "text": "A 24 year old female presented with sudden onset palpitations perceived as increased heart rate. It was followed by increased urine frequency. On examination pulse rate -170/min, BP-110/70 mmHg, CVS-no murmurs heard. ECG done is shown in the figure. You made a diagnosis of Supraventricular tachycardia. Carotid massage and adenosine failed to control the heart rate. You gave IV verapamil. ECG rhythm showed ventricular tachycardia now. Which of the following underlying cause most likely led to this situation in which SVT deteriorates to VT after the use of verapamil?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/8(250).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8263751",
      "question_audio": null,
      "question_video": null,
      "map_id": 34193625,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) WPW Syndrome Wolff-Parkinson-White (WPW) syndrome is the most likely underlying cause in this scenario. WPW syndrome is characterized by the presence of an accessory pathway (Bundle of Kent) that allows abnormal conduction between the atria and ventricles, bypassing the AV node. In patients with WPW, supraventricular tachycardia (SVT) may occur due to reentrant mechanisms involving the accessory pathway. Verapamils role: Verapamil is a calcium channel blocker that slows AV nodal conduction. In WPW syndrome, blocking the AV node can enhance conduction through the accessory pathway, potentially leading to ventricular tachycardia (VT) or even ventricular fibrillation. Clues in the case: The abrupt onset of palpitations, ECG showing SVT, and the progression to VT after verapamil strongly suggest WPW syndrome as the underlying cause. Increased urine frequency may occur due to the release of atrial natriuretic peptide during tachycardia. Option A: Dilated Cardiomyopathy Dilated cardiomyopathy (DCM) is associated with atrial and ventricular arrhythmias due to structural remodeling and electrical instability. However, DCM is less likely in this young patient with normal blood pressure and no signs of cardiac dysfunction on examination. Additionally, DCM does not typically lead to SVT converting to VT after verapamil. Option B: Hypertrophic Cardiomyopathy (HCM) HCM is a potential cause of arrhythmias, including SVT and VT, due to myocardial disarray and fibrosis. However, this patient has no signs of HCM, such as systolic murmurs or echocardiographic findings of left ventricular hypertrophy. Furthermore, the described progression (SVT to VT after verapamil) is more specific to WPW syndrome than HCM. Option D: Brugada Syndrome Brugada syndrome is a genetic condition associated with ventricular arrhythmias and sudden cardiac death. It is characterized by specific ECG patterns, such as coved ST-segment elevation in leads V1-V3. There is no mention of such ECG findings or a history suggestive of Brugada syndrome in this patient. Moreover, Brugada syndrome is unrelated to the use of verapamil causing a transition from SVT to VT.",
      "correct_choice_id": 218058,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61286741705729478/61286741705729478.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61286741705729478/61286741705729478.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75727,
      "choices": [
        {
          "id": 218060,
          "text": "Increase betablocker dose"
        },
        {
          "id": 218061,
          "text": "Amiodarone"
        },
        {
          "id": 218062,
          "text": "ICD"
        },
        {
          "id": 218063,
          "text": "Pacemaker"
        }
      ],
      "text": "In continuation with clinical vignette in previous patient was started on betablocker. After one year patient developed multiple episodes of ventricular arrythmias requiring DC shock. What will be most appropriate treatment for him",
      "unique_key": "Q4385166",
      "question_audio": null,
      "question_video": null,
      "map_id": 34245475,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) ICD (Implantable Cardioverter Defibrillator). This patient with Hypertrophic Cardiomyopathy (HCM) has developed multiple episodes of ventricular arrhythmias, which are life-threatening and have required DC shocks. The most appropriate treatment in this situation is the placement of an Implantable Cardioverter Defibrillator (ICD). ICDs are standard treatment for patients with HCM who have recurrent ventricular arrhythmias or are at high risk for sudden cardiac death. The ICD can monitor the hearts rhythm and deliver shocks to restore normal rhythm if a life-threatening arrhythmia (such as ventricular fibrillation or ventricular tachycardia) occurs. Given this patient's episodes of ventricular arrhythmias, an ICD is essential to prevent sudden cardiac death. Reasons for Incorrect Options: A. Increase beta-blocker dose: While beta-blockers are the first-line treatment for symptomatic HCM and can help control heart rate and reduce outflow obstruction, they are not sufficient for treating ventricular arrhythmias once they have developed. Beta-blockers may help with symptom control, but they do not prevent life-threatening arrhythmias in this patient, who is at high risk of sudden cardiac death. Increasing the beta-blocker dose would not address the arrhythmic risk adequately. B. Amiodarone: Amiodarone is an antiarrhythmic medication that can be used to manage arrhythmias, but it is generally considered a secondary treatment for patients who have failed beta-blockers or have recurrent arrhythmias despite adequate beta-blocker therapy. In this patient, the presence of ventricular arrhythmias with a high risk of sudden cardiac death necessitates the use of an ICD rather than relying on amiodarone alone. The ICD provides more effective and immediate protection against lethal arrhythmias. D. Pacemaker: A pacemaker is used for managing bradyarrhythmias (slow heart rates) and can be helpful in patients with heart block or symptomatic bradycardia, but it is not used to treat ventricular arrhythmias. Since this patient is experiencing ventricular arrhythmias, a pacemaker is not indicated. An ICD, rather than a pacemaker, is needed to address the risk of sudden cardiac death from ventricular arrhythmias.",
      "correct_choice_id": 218062,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16758931705729783/16758931705729783.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16758931705729783/16758931705729783.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75728,
      "choices": [
        {
          "id": 218064,
          "text": "Magnesium"
        },
        {
          "id": 218065,
          "text": "Dual-chamber pacemaker"
        },
        {
          "id": 218066,
          "text": "Beta blocker and an implantable cardioverter-defibrillator"
        },
        {
          "id": 218067,
          "text": "Observation"
        }
      ],
      "text": "A 14-year-old boy suffers two episodes of sudden syncope during gym class while jogging and is referred for further evaluation. His paternal uncle had died suddenly during physical exercise at age 20. Laboratory evaluation includes an ECG that shows normal sinus rhythm with a normal QTc interval. Cardiac magnetic resonance imaging reveals a structurally normal heart. Computed tomography angiography demonstrates normal coronary anatomy. He undergoes treadmill exercise testing, and the rhythm displayed in Figure is noted after 3 minutes of exercise.<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/Q%2036(1).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9563606",
      "question_audio": null,
      "question_video": null,
      "map_id": 34595401,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Beta blocker and an implantable cardioverter-defibrillator (ICD). This 14-year-old boy has experienced syncope during exercise and has a family history of sudden death during physical exertion, suggesting a genetic arrhythmic disorder such as arrhythmogenic right ventricular cardiomyopathy (ARVC) or catecholaminergic polymorphic ventricular tachycardia (CPVT). While the heart appears structurally normal on cardiac MRI, the exercise-induced rhythm seen in the treadmill testing (likely a ventricular arrhythmia) is concerning. The best treatment in this case is the combination of beta blockers, which can reduce arrhythmic events in CPVT or ARVC, and an implantable cardioverter-defibrillator (ICD), which can deliver shocks to restore normal rhythm in case of life-threatening arrhythmias. This combination is typically used in patients with high-risk arrhythmic syndromes, particularly if there's a family history of sudden cardiac death and syncope. ICD implantation is a primary strategy to prevent sudden cardiac death in patients with arrhythmic disorders like CPVT or ARVC. Reasons for Incorrect Responses: A. Magnesium: Magnesium is used in the management of torsades de pointes or hypomagnesemia-related arrhythmias, but this patient does not have evidence of these conditions. His ECG and cardiac imaging are normal, and his symptoms are most likely due to an inherited arrhythmic disorder. Magnesium is not the appropriate treatment for this case, which involves an underlying genetic condition associated with exercise-induced arrhythmias. B. Dual-chamber pacemaker: A dual-chamber pacemaker is used for conditions involving bradycardia or heart block. While this boy has syncope, the cause appears to be related to exercise-induced arrhythmias, not bradycardia. Pacemakers are not indicated in arrhythmic conditions like CPVT or ARVC unless there's concomitant conduction system disease, which is not suggested here. Therefore, a pacemaker would not be the appropriate choice in this case. D. Observation: Given the patient's family history of sudden cardiac death, syncope during exercise, and the finding of an arrhythmia during treadmill exercise testing, observation alone would not be sufficient. This patient is at high risk for future arrhythmic events, and therefore, active management with beta blockers and an ICD is indicated to prevent sudden death.",
      "correct_choice_id": 218066,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27873461705730439/27873461705730439.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27873461705730439/27873461705730439.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75729,
      "choices": [
        {
          "id": 218068,
          "text": "Amiodarone"
        },
        {
          "id": 218069,
          "text": "Sotalol"
        },
        {
          "id": 218070,
          "text": "Disopyramide"
        },
        {
          "id": 218071,
          "text": "Dofetilide on OPD basis"
        }
      ],
      "text": "A 72-year-old man with nonischemic dilated cardiomyopathy, left ventricular ejection fraction 38%, New York Heart Association class III symptoms, and chronic kidney disease (creatinine = 2.8 mg/dL) presents with symptomatic paroxysmal atrial fibrillation. Electrocardiography when in sinus rhythm shows a corrected QT interval of 442 milliseconds. Which of the following is the most appropriate initial oral antiarrhythmic regimen to maintain sinus rhythm in this patient?",
      "unique_key": "Q7056783",
      "question_audio": null,
      "question_video": null,
      "map_id": 34371632,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Amiodarone In this 72-year-old patient with nonischemic dilated cardiomyopathy, paroxysmal atrial fibrillation (AF), and chronic kidney disease, the most appropriate initial oral antiarrhythmic regimen to maintain sinus rhythm is amiodarone. Amiodarone is a class III antiarrhythmic that is particularly effective in maintaining sinus rhythm in patients with heart failure or left ventricular dysfunction, such as this patient with a left ventricular ejection fraction of 38%. It is preferred in these patients because of its efficacy in maintaining sinus rhythm and its ability to reduce the risk of proarrhythmia, especially compared to other antiarrhythmic drugs that may have a higher risk of exacerbating heart failure or causing arrhythmias. Additionally, amiodarone has a long half-life, so it can be started orally in the outpatient setting and provide effective rhythm control. Incorrect Responses: B. Sotalol: Sotalol is a class II and III antiarrhythmic, used for maintaining sinus rhythm in patients with atrial fibrillation. However, it has a significant downside in patients with heart failure or chronic kidney disease because it can cause proarrhythmia, especially in those with QT interval prolongation. Although this patient has a corrected QT interval of 442 milliseconds, which is within the normal range, sotalol should be avoided in those with significant renal dysfunction due to its renal excretion and potential for accumulating in the body, which increases the risk of adverse effects such as torsades de pointes. Therefore, amiodarone is a safer and more effective choice in this case. C. Disopyramide: Disopyramide is a class IA antiarrhythmic used for the treatment of atrial fibrillation and other arrhythmias. However, disopyramide has a negative inotropic effect, meaning it can worsen heart failure in patients with reduced ejection fractions like this patient. It can also cause anticholinergic effects, leading to urinary retention and dry mouth, which would be particularly problematic in elderly patients. Given this patient's heart failure, amiodarone is the preferred choice due to its more favorable safety profile in heart failure patients. D. Dofetilide on OPD basis: Dofetilide is a class III antiarrhythmic that can be used to maintain sinus rhythm in atrial fibrillation, but it is associated with a high risk of QT prolongation and torsades de pointes. It must be initiated in a hospital setting where QT monitoring is possible and where any proarrhythmic events can be managed promptly. Because this patient has chronic kidney disease, dofetilide is contraindicated in patients with renal impairment or significant creatinine clearance reductions due to the increased risk of QT prolongation and arrhythmic events. Thus, amiodarone is a more appropriate initial choice.",
      "correct_choice_id": 218068,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35674321705730456/35674321705730456.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35674321705730456/35674321705730456.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75730,
      "choices": [
        {
          "id": 218072,
          "text": "Administration of intravenous ibutilide before electrical cardioversion facilitates successful conversion of AF to normal sinus rhythm"
        },
        {
          "id": 218073,
          "text": "Electrical cardioversion is most effective at terminating tachycardias that arise from enhanced automaticity"
        },
        {
          "id": 218074,
          "text": "Repeated shocks at the same energy level increase chest wall impedance"
        },
        {
          "id": 218075,
          "text": "Rivaroxaban can be safely discontinued 7 days after successful cardioversion if sinus rhythm is achieved"
        }
      ],
      "text": "A 53-year-old man with symptomatic atrial fibrillation presents for elective outpatient cardioversion. For the past 3 months he has been taking appropriately dosed rivaroxaban as an anticoagulant, and diltiazem for rate control. Now his heart rate is 80/min,BP-110/80 mmHg, chest is clear on auscultation. ECHO shows no evidence of atrial thrombus. Which of the following statements about external electrical cardioversion is correct?",
      "unique_key": "Q5600456",
      "question_audio": null,
      "question_video": null,
      "map_id": 34711211,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Electrical cardioversion is very effective for termination of supraventricular and ventricular tachyarrhythmias, particularly those due to reentry. The cardioversion of tachycardias caused by disorders of enhanced automaticity is less successful. For example, ectopic atrial tachycardia and other arrhythmias caused by disorders of impulse formation typically recur within seconds after the electrical discharge. Except in patients with ventricular fibrillation or rapid ventricular flutter, a synchronized shock (delivered during the QRS complex) should be used to minimize the risk of firing on the ST segment or T wave, which might precipitate ventricular fibrillation. The minimal effective energy should be employed initially to reduce the risk of myocardial damage, with upward titration as required. If the maximum energy level of the electrical cardioverter fails to terminate the abnormal rhythm, repeated shocks at the same energy level can decrease the chest wall impedance and may succeed. Treatment with the class III intravenous agent ibutilide may convert atrial fibrillation to sinus rhythm, and when used as pretreatment also enhances the success of subsequent electrical cardioversion. After successful cardioversion, anticoagulation should be continued for an additional 3 to 4 weeks because full recovery of atrial mechanical activity often lags behind the return of normal electrical function and persistent blood stasis could permit thrombus formation.",
      "correct_choice_id": 218072,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58819101705730473/58819101705730473.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58819101705730473/58819101705730473.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75731,
      "choices": [
        {
          "id": 218076,
          "text": "Aspirin"
        },
        {
          "id": 218077,
          "text": "Enoxaparin"
        },
        {
          "id": 218078,
          "text": "Implantation of a left atrial appendage closure device"
        },
        {
          "id": 218079,
          "text": "No treatment needed"
        }
      ],
      "text": "An 80-year-old man with permanent rate-controlled atrial fibrillation, hypertension, diabetes, chronic kidney disease (serum creatinine 2.5 mg/dL), and spinal stenosis has sustained three mechanical falls over the past year, without serious injury. He has a history of occasional lower gastrointestinal bleeding without a source of blood loss identified by upper, lower, and capsule endoscopy. Of the following, which is the most appropriate method for stroke prevention in this patient?",
      "unique_key": "Q1092239",
      "question_audio": null,
      "question_video": null,
      "map_id": 34879353,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Implantation of a left atrial appendage closure device Nearly all left atrial thrombi form in the left atrial appendage (LAA).Surgical or percutaneous device exclusion of the LAA may reduce thromboembolic complications in patients with atrial fibrillation (AF), especially in those who are not candidates for long-term anticoagulation. This patient is at high risk for stroke (CHA2DS2-VASc score is 4, with 1 point for hypertension, 1 point for diabetes, and 2 points for age 75 years) such that aspirin alone would be insufficient to reduce stroke risk. The patient has also had recurrent falls and repetitive gastrointestinal bleeding that increase the risk for bleeding events on anticoagulation, such that implantation of an LAA closure device is a reasonable option. In chronic kidney disease, the elimination of enoxaparin is prolonged, the bleeding risk is increased, and it would not be an appropriate choice for this patients chronic anticoagulation.",
      "correct_choice_id": 218078,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53770251705730489/53770251705730489.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53770251705730489/53770251705730489.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75732,
      "choices": [
        {
          "id": 218080,
          "text": "Caffeine"
        },
        {
          "id": 218081,
          "text": "Cocaine"
        },
        {
          "id": 218082,
          "text": "Alcohol"
        },
        {
          "id": 218083,
          "text": "Hypertension"
        }
      ],
      "text": "A 26-year-old construction worker comes to the emergency department with palpitations. On ECG atrial fibrillation was noted. He states that for the past few months he has had occasional episodes of palpitations, almost always on Mondays. His vital signs include heart rate of 140 beats/min, respirations of 16 breaths/min, and blood pressure of 160/95 mm Hg. is physical examination is unremarkable. While being observed in the hospital, he spontaneously reverts to normal sinus rhythm. The most likely precipitating cause is",
      "unique_key": "Q8083402",
      "question_audio": null,
      "question_video": null,
      "map_id": 34586296,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) alcohol The most likely precipitating cause of this patient's atrial fibrillation (AF) is alcohol (Choice C). This individuals history of episodic palpitations, particularly on Mondays, suggests that these episodes are likely linked to alcohol consumption, which is a common trigger for \"holiday heart syndrome.\" This syndrome refers to the occurrence of atrial fibrillation after heavy drinking, often after weekends or social gatherings. The patient's sudden reversion to normal sinus rhythm while in the hospital also supports the idea that the AF was triggered by alcohol. Alcohol can cause changes in electrolyte levels, autonomic tone, and direct effects on the heart, all of which may precipitate AF. Incorrect Options: Caffeine (Choice A): While caffeine can induce palpitations and lead to arrhythmias in some people, it is not the most likely cause here. Caffeine-induced arrhythmias are typically seen in a more acute setting and are often accompanied by other symptoms, such as jitteriness or anxiety, which this patient does not report. Additionally, the pattern of palpitations on Mondays strongly points to alcohol consumption rather than caffeine intake. Cocaine (Choice B): Cocaine use is a known cause of arrhythmias, including atrial fibrillation, due to its sympathomimetic effects that can increase heart rate and blood pressure. However, there is no mention of cocaine use in this patients history, making it less likely to be the precipitating factor. The patient also doesn't exhibit signs of acute drug intoxication, further supporting this option as unlikely. Hypertension (Choice D): Chronic hypertension is a well-known risk factor for atrial fibrillation; however, this patients presentation is acute, with the AF resolving spontaneously, which makes hypertension a less likely cause in this scenario. Additionally, the patient does not have a long-standing history of high blood pressure or signs of hypertensive heart disease, reducing the likelihood that hypertension is the trigger.",
      "correct_choice_id": 218082,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37115861705730533/37115861705730533.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37115861705730533/37115861705730533.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75733,
      "choices": [
        {
          "id": 218084,
          "text": "The abnormality in the right atrium is most likely a thrombus"
        },
        {
          "id": 218085,
          "text": "This lesion is more likely to develop in the right atrium than the left atrium"
        },
        {
          "id": 218086,
          "text": "Embolism from this lesion is common"
        },
        {
          "id": 218087,
          "text": "The presence of fever would be indicative of active infection"
        }
      ],
      "text": "A 34-year-old woman presents with recurrent syncope. In recent months she has noted a 10 kg unintentional weight loss, malaise, and diffuse arthralgias. She denies dyspnea, palpitations, or chest pain. Clubbing is present and early diastolic low pitch sound is heard on auscultation. A two-dimensional echocardiogram shows a pedunculated mass in right atria. Which of the following statements is TRUE about this patients condition?",
      "unique_key": "Q5691933",
      "question_audio": null,
      "question_video": null,
      "map_id": 34969051,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) The echocardiogram demonstrates a pedunculated mass in the right atrium that is most suggestive of an atrial myxoma. Features that suggest myxoma include (1) attachment of the mass to the interatrial septum (the most common site of attachment is in the region of the fossa ovalis) and (2) a mass that is pedunculated and heterogeneous in appearance. Other cardiac tumors, including lipomas and rhabdomyomas, would be within the differential diagnosis. However, these other tumors are rarely pedunculated and more often infiltrate into the myocardium itself. Atrial myxoma is the most common primary tumor of the heart, and >80% of such tumors arise in the left atrium. The clinical presentation of a myxoma is related to intracardiac obstruction, embolization, and/or constitutional symptoms. Nearly 70% of patients with left atrial myxomas have cardiac symptoms, typically related to obstructive heart failure and syncope. Embolic events occur commonly with left atrial myxomas causing strokes and transient ischemic attacks and right atrial myxomas leading to pulmonary emboli. Myxomas may secrete interleukin-6, an inflammatory cytokine associated with systemic symptoms such as fever, malaise, and weight loss. Surgical resection of myxomas is warranted to relieve systemic or intracardiac obstructive symptoms and to prevent embolic complications.",
      "correct_choice_id": 218086,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28658471705730765/28658471705730765.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28658471705730765/28658471705730765.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75734,
      "choices": [
        {
          "id": 218088,
          "text": "Rivaroxaban"
        },
        {
          "id": 218089,
          "text": "Apixaban"
        },
        {
          "id": 218090,
          "text": "Dabigatran"
        },
        {
          "id": 218091,
          "text": "Warfarin"
        }
      ],
      "text": "A 66-year-old man with end-stage renal disease and hypertension on hemodialysis presented with palpitations. On examination- Pulse is irregular with pulse deficit present. JVP has absent a waves. ECG showed atrial fibrillation. His CHA2DS2-VAS score is 2. It is determined that he needs anticoagulation for stroke prevention. Which of the following agents is safe for use in patients on hemodialysis?",
      "unique_key": "Q2384967",
      "question_audio": null,
      "question_video": null,
      "map_id": 34791206,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) The direct thrombin inhibitor dabigatran, and the factor X a inhibitors rivaroxaban, apixaban, and edoxaban, are non vitamin K antagonist oral anticoagulants (NOACs) for the prevention of stroke in patients with nonvalvular atrial fibrillation (AF), and the treatment of deep venous thrombosis and pulmonary embolism. Each of these agents is in part cleared through renal excretion, and the doses of all four agents must be lowered in patients with reduced creatinine clearance. For patients with end-stage renal disease, and for those on dialysis warfarin is safe which currently remains the anticoagulant of choice in these conditions.",
      "correct_choice_id": 218091,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51571431705731475/51571431705731475.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51571431705731475/51571431705731475.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75735,
      "choices": [
        {
          "id": 218092,
          "text": "Amiodarone inhibits the peripheral conversion of thyroxine (T4) to triiodothyronine (T3)"
        },
        {
          "id": 218093,
          "text": "During initial therapy, amiodarone decreases thyroid stimulating hormone levels"
        },
        {
          "id": 218094,
          "text": "Glucocorticoid therapy is beneficial for patients with amiodarone-induced hyperthyroidism who have elevated circulating levels of interleukin-6"
        },
        {
          "id": 218095,
          "text": "Amiodarones iodine content inhibits synthesis and release of T4 from the thyroid gland"
        }
      ],
      "text": "A 66-year-old man with a history of atrial fibrillation successfully suppressed by amiodarone presents with tremors and recent weight loss. On examination tremors of outstretched hands present. Pulse is 120/min,BP160/60 mmHg, CVS-tachycardia, lungs-clear. His physician suspects amiodarone induced thyroid dysfunction. Which of the following statements about amiodarone and thyroid function is NOT correct?",
      "unique_key": "Q6643537",
      "question_audio": null,
      "question_video": null,
      "map_id": 34196310,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Amiodarone, a potent class III antiarrhythmic agent, has two primary effects on thyroid function. First, it inhibits the peripheral conversion of thyroxine (T4) to triiodothyronine (T3), causing a reduction of serum T3 and a transient rise in thyroid-stimulating hormone (TSH). Within a short time, however, a compensatory increase in serum T4 levels occurs and TSH returns to normal. Clinically, such patients are euthyroid, even though T4 levels are elevated. Amiodarones second effect relates to its large content of iodine (30% by weight), which inhibits synthesis and release of T4 from the thyroid gland, causing a more sustained rise in TSH. In some patients, especially those with underlying thyroid disease, clinical hypothyroidism and a marked rise in TSH result. Amiodarone-induced hyperthyroidism is less common and may arise from two distinct mechanisms. Type I develops primarily in individuals with underlying thyroid disease, typically in iodine-deficient environments. Such patients display evidence of thyroid autoimmunity, including antithyroid antibodies. In contrast, type II is a form of thyroiditis that develops in a previously normal gland, presumably mediated by proinflammatory cytokines, marked by an elevation of circulating interleukin-6. This condition is a thyroid-destructive process, and hyperthyroidism results from release of preformed thyroid hormone, a situation that can persist for months. Unlike type I, this form of hyperthyroidism tends to respond to glucocorticoid therapy.",
      "correct_choice_id": 218093,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73474941705731783/73474941705731783.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73474941705731783/73474941705731783.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75736,
      "choices": [
        {
          "id": 218096,
          "text": "Sinus tachycardia"
        },
        {
          "id": 218097,
          "text": "Paroxysmal supraventricular tachycardia (PSVT)"
        },
        {
          "id": 218098,
          "text": "Atrial flutter"
        },
        {
          "id": 218099,
          "text": "Ventricular tachycardia"
        }
      ],
      "text": "A 22-year-old woman complains of palpitations which is sudden onset. There is no significant past medical history. On examination pulse is 150/min and regular. JVP showed cannon a waves. Blood pressure is 110/70 mm Hg. The rate abruptly changes to 75/min after applying carotid sinus pressure. Now she c/o of increased urine output. ECG is shown in the figure. Which of the following is the most likely diagnosis?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/28(107).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9789734",
      "question_audio": null,
      "question_video": null,
      "map_id": 34342305,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Paroxysmal supraventricular tachycardia (PSVT). Correct Response: Paroxysmal supraventricular tachycardia (PSVT) This patient presents with sudden-onset palpitations, a regular pulse rate of 150/min, and cannon a waves seen on the jugular venous pressure (JVP). Cannon a waves are caused by atrial contraction against a closed tricuspid valve, which is seen in conditions like AV nodal reentrant tachycardia (AVNRT) or atrioventricular reciprocating tachycardia (AVRT), both of which are types of PSVT. The abrupt rate change to 75/min after carotid sinus pressure indicates vagal maneuver effectiveness, which is often used to terminate PSVT. The increased urine output is a known effect of the vagal response (due to increased parasympathetic tone). On ECG, PSVT typically shows narrow QRS complexes with a regular rhythm and a rapid heart rate, consistent with this patients findings. PSVT is characterized by a paroxysmal (sudden onset and termination) episode of regular, rapid supraventricular tachycardia. Incorrect Responses: (A) Sinus tachycardia This statement is incorrect because sinus tachycardia typically occurs in response to physiological stressors like exercise, fever, or anxiety. It is characterized by a gradual onset and normal P waves preceding each QRS complex. The sudden onset and abrupt rate change with vagal maneuvers (as seen in this patient) are not typical of sinus tachycardia. Additionally, cannon a waves and the ECG findings in PSVT are not characteristic of sinus tachycardia. (C) Atrial flutter This statement is incorrect because atrial flutter typically presents with a regular rhythm, but with atrial rates of 250-350/min, leading to a characteristic sawtooth pattern on the ECG. This is not observed in this patient's ECG, which shows a regular narrow complex tachycardia without the typical flutter waves. Atrial flutter is also less likely to respond as dramatically to carotid sinus massage, as seen in PSVT. (D) Ventricular tachycardia This statement is incorrect because ventricular tachycardia (VT) usually presents with wide QRS complexes and is often associated with hemodynamic instability and chest pain. VT is less likely to present with regular palpitations and a narrow QRS complex, as seen in this patient. VT also does not respond to vagal maneuvers as PSVT does.",
      "correct_choice_id": 218097,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46642581705731967/46642581705731967.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46642581705731967/46642581705731967.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75737,
      "choices": [
        {
          "id": 218100,
          "text": "Sinus bradycardia"
        },
        {
          "id": 218101,
          "text": "Independent beating of atria and ventricles"
        },
        {
          "id": 218102,
          "text": "A reentry phenomenon"
        },
        {
          "id": 218103,
          "text": "Age related physiological change"
        }
      ],
      "text": "A 69-year-old woman complains of easy fatigue and one episode of presyncope. There is no past history of valvular heart disease or hypertension. She is not taking any medicines. On examination pulse is 50/min and regular, BP-140/60 mmHg. In jugular venous pressure (JVP), there are irregular cannon a waves. ECG is shown in figure and reveals fixed PP and RR intervals but varying PR intervals. Which of the following conditions is this most likely caused by?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/31(102).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6833175",
      "question_audio": null,
      "question_video": null,
      "map_id": 34925105,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Independent beating of atria and ventricles. Correct Response: Independent beating of atria and ventricles The patient's symptoms, including easy fatigue, presyncope, a pulse of 50/min, and irregular cannon a waves on jugular venous pressure (JVP), along with the ECG findings showing fixed PP and RR intervals but varying PR intervals, point towards complete heart block (also known as third-degree AV block). In this condition, the atria and ventricles beat independently because the normal conduction between the atria and ventricles is blocked. The cannon a waves on JVP occur due to the atria contracting against a closed tricuspid valve when the atria and ventricles are out of sync. The ECG findings are characteristic of third-degree AV block, where the atrial and ventricular rhythms are dissociated, leading to the fixed P-P intervals (atrial rate) and R-R intervals (ventricular rate), but the PR interval varies because the atrial impulses are not consistently conducted to the ventricles. Incorrect Responses: (A) Sinus bradycardia This statement is incorrect because sinus bradycardia refers to a slow but regular heart rate originating from the sinoatrial node. It would not cause the irregular cannon a waves or the dissociation between atrial and ventricular rhythms that is seen in this patient. In sinus bradycardia, the P wave and R wave are typically regular and related, and there would not be varying PR intervals as seen in third-degree AV block. (C) A reentry phenomenon This statement is incorrect because a reentry phenomenon typically refers to a condition where an electrical impulse circles back to re-excite parts of the heart, leading to arrhythmias such as atrial fibrillation, atrial flutter, or ventricular tachycardia. However, reentry does not explain the findings of complete dissociation between atria and ventricles or the cannon a waves seen in third-degree AV block. Reentry arrhythmias are usually associated with rapid, regular rhythms, unlike the irregularity seen in this case. (D) Age-related physiological change This statement is incorrect because while some degree of heart block can be seen with aging, the findings described heresuch as cannon a waves and the ECG with varying PR intervalsare not typical of a normal, age-related physiological change. Complete heart block is a pathological condition, and although first-degree AV block may become more common with age, it does not typically present with the symptoms and findings described in this case./",
      "correct_choice_id": 218101,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78077291705732026/78077291705732026.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78077291705732026/78077291705732026.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}